|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/48 | |
| A61P 17/00 | |||
| A61P 29/00 |
| (11) | Patento numeris | 2037956 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07788861.8 |
| Europos patento paraiškos padavimo data | 2007-06-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-03-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-12-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/FR2007/000956 |
| Data | 2007-06-11 |
| (87) | Numeris | WO 2007/144493 |
| Data | 2007-12-21 |
| (30) | Numeris | Data | Šalis |
| 0605368 | 2006-06-16 | FR |
| (72) |
AUGUET, Michel, FR
FAVRE, Christine, FR
CHABRIER DE LASSAUNIERE, Pierre-Etienne, FR
|
| (73) |
IPSEN PHARMA,
65 Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
|
| (54) | UTILISATION THERAPEUTIQUE SIMULTANEE, SEPAREE OU ETALEE DANS LE TEMPS D`AU MOINS UNE NEUROTOXINE BOTULIQUE, ET D`AU MOINS UN DERIVE OPIACE |
| SIMULTANEOUS, SEPARATE OR SEQUENTIAL THERAPEUTIC USE OF AT LEAST ONE BOTULINUM NEUROTOXIN AND OF AT LEAST ONE OPIATE DERIVATIVE |